✦ LIBER ✦

Phase II evaluation of vinblastine, methotrexate, and calcium leukovorin rescue in patients with refractory metastatic breast cancer

✍ Scribed by G. N. Hortobagyi; H.-Y. Yap; G. R. Blumenschein; A. U. Buzdar; B. C. Barnes; S. S. Legha; C. L. Wiseman

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 322 KB
Volume: 51
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19830301)51:5<769::aid-cncr2820510503>3.0.co;2-s

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methotrexate, vinblastine, doxorubicin,

Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the hoosier oncology group

✍ Bruce J. Roth; George W. Sledge Jr; Stephen D. Williams; Steven C. Meyer; Rafat 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 2 views

Forty-six eligible patients with metastatic breast cancer (MBC) were treated with a combination of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) as first-line chemotherapy. Of 44 patients evaluable for response, 28 (64%) had an objective response, including seven (16%) who had a comp

A Phase II trial of docetaxel and estram

A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma

✍ Amy D. Tiersten; Caron Nelsen; Susan Talbot; Linda Vahdat; Robert Fine; Andrea T 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

## Abstract ## BACKGROUND The similarity between the mechanism of action between docetaxel and estramustine generated the hypothesis of synergistic antimicrotubule effects and cytotoxicity when the two agents are combined. In addition, it has been demonstrated that estramustine binds P‐glycoprotei

Carboplatin, methotrexate, and vinblasti

Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trial

✍ Francesco Boccardo; Maurizio Pace; Domenico Guarneri; Luciano Canobbio; Antonio 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 3 views

Phase II study of paclitaxel in patients

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy

✍ Edgardo Rivera; Frankie A. Holmes; Debra Frye; Vicente Valero; Richard L. Theria 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

Phase II clinical and pharmacological st

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer

✍ John A. Benvenuto; Robert A. Newman; Gary S. Bignami; T. J. G. Raybould; Martin 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 342 KB

Phase II trial of intermediate dose meth

Phase II trial of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma

✍ Paul M. Dodd; John A. McCaffrey; Madhu Mazumdar; Howard Scher; Vaia Vlamis; Gera 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 3 views

## Background: This study was undertaken to determine whether the use of intermediate dose methotrexate in combination with vinblastine, doxorubicin, and cisplatin as first-line therapy increases the proportion of major responders and overall survival in patients with unresectable or metastatic tra